Exhibit 10.2
TRANSCEPT PHARMACEUTICALS,
INC.
AMENDED AND RESTATED 2002 STOCK
OPTION PLAN
STOCK OPTION
AGREEMENT
Unless otherwise defined herein, the
terms defined in the Amended and Restated 2002 Stock Option Plan
shall have the same defined meanings in this Stock Option
Agreement.
|
I.
|
NOTICE OF
STOCK OPTION GRANT
|
Name: «Name»
Address:
The undersigned Optionee has been
granted an Option to purchase Common Stock of the Company, subject
to the terms and conditions of the Plan and this Option Agreement,
as follows:
|
|
|
|
|
|
Date of Grant
|
|
«DOG»
|
|
|
|
Vesting Commencement Date
|
|
«VCD»
|
|
|
|
Exercise Price per Share
|
|
$1.12
|
|
|
|
Total Number of Shares Granted
|
|
«Shares»
|
|
|
|
Total Exercise Price
|
|
$«ExPrice»
|
|
|
|
Type of Option:
|
|
x Incentive Stock Option
|
|
|
|
|
¨ Nonstatutory Stock Option
|
|
|
|
Term/Expiration
Date:
|
|
«ExpDate»
|
Vesting Schedule
:
This Option shall be exercisable, in
whole or in part, according to the following vesting
schedule:
25% of the Shares subject to the
Option shall vest on the one (1) year anniversary of the
Vesting Commencement Date, and 1/48 of the Shares subject to the
Option shall vest on the «Day» day of each full month
thereafter, subject to Optionee continuing to be a Service Provider
on such dates.
Termination Period
:
This Option shall be exercisable for
thirty (30) days after Optionee ceases to be a Service
Provider. Upon Optionee’s death or Disability, this Option
may be exercised for one (1) year after Optionee ceases to be
a Service Provider. In no event may Optionee exercise this Option
after the Term/Expiration Date as provided above.
1. Grant of Option . The Plan
Administrator of the Company hereby grants to the Optionee named in
the Notice of Grant (the “Optionee”), an option (the
“Option”) to purchase the number of Shares set forth in
the Notice of Grant, at the exercise price per Share set forth in
the Notice of Grant (the “Exercise Price”), and subject
to the terms and conditions of the Plan, which is incorporated
herein by reference. Subject to Section 15(c) of the Plan, in
the event of a conflict between the terms and conditions of the
Plan and this Option Agreement, the terms and conditions of the
Plan shall prevail.
If designated in the Notice of Grant
as an Incentive Stock Option (“ISO”), this Option is
intended to qualify as an Incentive Stock Option as defined in
Section 422 of the Code. Nevertheless, to the extent that it
exceeds the $100,000 rule of Code Section 422(d), this Option
shall be treated as a Nonstatutory Stock Option
(“NSO”).
2. Exercise of Option
.
(a) Right to Exercise . This
Option shall be exercisable during its term in accordance with the
Vesting Schedule set out in the Notice of Grant and with the
applicable provisions of the Plan and this Option
Agreement.
(b) Method of Exercise . This
Option shall be exercisable by delivery of an exercise notice in
the form attached as Exhibit A (the “Exercise
Notice”) which shall state the election to exercise the
Option, the number of Shares with respect to which the Option is
being exercised, and such other representations and agreements as
may be required by the Company. The Exercise Notice shall be
accompanied by payment of the aggregate Exercise Price as to all
Exercised Shares. This Option shall be deemed to be exercised upon
receipt by the Company of such fully executed Exercise Notice
accompanied by the aggregate Exercise Price.
No Shares shall be issued pursuant
to the exercise of an Option unless such issuance and such exercise
complies with Applicable Laws. Assuming such compliance, for income
tax purposes the Shares shall be considered transferred to the
Optionee on the date on which the Option is exercised with respect
to such Shares.
3. Optionee’s
Representations . In the event the Shares have not been
registered under the Securities Act of 1933, as amended, at the
time this Option is exercised, the Optionee shall, if required by
the Company, concurrently with the exercise of all or any portion
of this Option, deliver to the Company his or her Investment
Representation Statement in the form attached hereto as
Exhibit B .
-2-
4. Lock-Up Period . Optionee
hereby agrees that Optionee shall not offer, pledge, sell, contract
to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to
purchase, lend, or otherwise transfer or dispose of, directly or
indirectly, any Common Stock (or other securities) of the Company
or enter into any swap, hedging or other arrangement that transfers
to another, in whole or in part, any of the economic consequences
of ownership of any Common Stock (or other securities) of the
Company held by Optionee (other than those included in the
registration) for a period specified by the representative of the
underwriters of Common Stock (or other securities) of the Company
not to exceed one hundred eighty (180) days following the
effective date of any registration statement of the Company filed
under the Securities Act.
Optionee agrees to execute and
deliver such other agreements as may be reasonably requested by the
Company or the underwriter which are consistent with the foregoing
or which are necessary to give further effect thereto. In addition,
if requested by the Company or the representative of the
underwriters of Common Stock (or other securities) of the Company,
Optionee shall provide, within ten (10) days of such request,
such information as may be required by the Company or such
representative in connection with the completion of any public
offering of the Company’s securities pursuant to a
registration statement filed under the Securities Act. The
obligations described in this Section shall not apply to a
registration relating solely to employee benefit plans on Form S-1
or Form S-8 or similar forms that may be promulgated in the future,
or a registration relating solely to a Commission Rule 145
transaction on Form S-4 or similar forms that may be promulgated in
the future. The Company may impose stop-transfer instructions with
respect to the shares of Common Stock (or other securities) subject
to the foregoing restriction until the end of said one hundred
eighty (180) day period. Optionee agrees that any transferee
of the Option or shares acquired pursuant to the Option shall be
bound by this Section.
5. Method of Payment .
Payment of the aggregate Exercise Price shall be by any of the
following, or a combination thereof, at the election of the
Optionee:
(a) cash or check;
(b) consideration received by the
Company under a formal cashless exercise program adopted by the
Company in connection with the Plan; or
(c) surrender of other Shares which,
(i) in the case of Shares acquired from the Company, either
directly or indirectly, have been owned by the Optionee for more
than six (6) months on the date of surrender, and
(ii) have a Fair Market Value on the date of surrender equal
to the aggregate Exercise Price of the Exercised Shares.
6. Restrictions on Exercise .
This Option may not be exercised until such time as the Plan has
been approved by the stockholders of the Company, or if the
issuance of such Shares upon such exercise or the method of payment
of consideration for such shares would constitute a violation of
any Applicable Law.
7. Non-Transferability of
Option . This Option may not be transferred in any manner
otherwise than by will or by the laws of descent or distribution
and may be exercised during the lifetime of Optionee only by
Optionee. The terms of the Plan and this Option Agreement shall be
binding upon the executors, administrators, heirs, successors and
assigns of the Optionee.
-3-
8. Term of Option . This
Option may be exercised only within the term set out in the Notice
of Grant, and may be exercised during such term only in accordance
with the Plan and the terms of this Option.
9. Tax Obligations
.
(a) Withholding Taxes .
Optionee agrees to make appropriate arrangements with the Company
(or the Parent or Subsidiary employing or retaining Optionee) for
the satisfaction of all Federal, state, local and foreign income
and employment tax withholding requirements applicable to the
Option exercise. Optionee acknowledges and agrees that the Company
may refuse to honor the exercise and refuse to deliver Shares if
such withholding amounts are not delivered at the time of
exercise.
(b) Notice of Disqualifying
Disposition of ISO Shares . If the Option granted to Optionee
herein is an ISO, and if Optionee sells or otherwise disposes of
any of the Shares acquired pursuant to the ISO on or before the
later of (1) the date two years after the Date of Grant, or
(2) the date one year after the date of exercise, the Optionee
shall immediately notify the Company in writing of such
disposition. Optionee agrees that Optionee may be subject to income
tax withholding by the Company on the compensation income
recognized by the Optionee.
10. Entire Agreement; Governing
Law . The Plan is incorporated herein by reference. The Plan
and this Option Agreement constitute the entire agreement of the
parties with respect to the subject matter hereof and supersede in
their entirety all prior undertakings and agreements of the Company
and Optionee with respect to the subject matter hereof, and may not
be modified adversely to the Optionee’s interest except by
means of a writing signed by the Company and Optionee. This
agreement is governed by the internal substantive laws but not the
choice of law rules of California .
11. No Guarantee of Continued
Service . OPTIONEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF
SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY
CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (NOT
THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR
ACQUIRING SHARES HEREUNDER). OPTIONEE FURTHER ACKNOWLEDGES AND
AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER
AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN
EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE
PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND
SHALL NOT INTERFERE IN ANY WAY WITH OPTIONEE’S RIGHT OR THE
COMPANY’S RIGHT TO TERMINATE OPTIONEE’S RELATIONSHIP AS
A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE.
Optionee acknowledges receipt of a
copy of the Plan and represents that he or she is familiar with the
terms and provisions thereof, and hereby accepts this Option
subject to all of the terms and provisions thereof. Optionee has
reviewed the Plan and this Option in their entirety, has had
an
-4-
opportunity to obtain the advice of counsel
prior to executing this Option and fully understands all provisions
of the Option. Optionee hereby agrees to accept as binding,
conclusive and final all decisions or interpretations of the
Administrator upon any questions arising under the Plan or this
Option. Optionee further agrees to notify the Company upon any
change in the residence address indicated below.
|
|
|
|
|
|
OPTIONEE
|
|
|
|
TRANSCEPT
PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
|
|
By
|
|
|
|
|
|
|
|
|
|
|
Print
Name
|
|
|
|
Title
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residence
Address
|
|
|
|
|